T Cell Initiated Gastric Pathology

T 细胞引发的胃病理学

基本信息

项目摘要

DESCRIPTION (provided by applicant): The bacteria Helicobacter pylori is a major pathogen which, in addition to infecting over half of the world's population, is linked to gastric and duodenal ulcer disease, mucosal-associated lymphomas, and adenocarcinoma. Infection with H. pylori results in an early gastric infiltration of neutrophils, macrophages, CD4+ T cells, and B cells. These gastric infiltrates are accompanied by increased levels of gastric IFN-gamma, TNF-alpha, and IL-1 and by loss of gastric parietal cells, zymogenic cells, and dysplasia of gastric mucosal cells. Very little is known about the mechanisms by which this gastric infiltrate induces subsequent gastric epithelial pathology. A small animal model of Helicobacter infection, the H. felis mouse model, closely mimics the human disease in that severe gastric atrophy and gastric adenocarcinoma develops after infection. This model has allowed a careful analysis of the adaptive immune response to Helicobacter infection. Using a novel adoptive transfer model of disease, we have shown that it is the host CD4+ T cell response which is crucial for the development of H. felis-associated gastric pathology. This has directed our attention to the role of the CD4+ T cell, and its potential effector mechanisms, in the development of Helicobacter-associated gastric epithelial cell destruction and pathology. This grant application focuses on the hypothesis that recruitment and activation of CD4+ T cells in the stomach results in secondary non-antigen specific gastric epithelial cell alterations. These changes in epithelial cell proliferation and differentiation lead to gastric dysplasia and cancer formation. In order to elucidate this immune/ epithelial cell relationship and its sequelae, we propose to: 1) characterize the antigen recognition requirements of the CD4+ T cell critical for the development of Helicobacter-associated gastric pathology; and 2) determine the role of secreted or cell-surface products in the generation of Helicobacter-associated gastric epithelial pathology. These studies will utilize both in vivo models of disease, as well as a novel primary gastric epithelial cell culture system. The understanding of the basic mechanisms by which the host immune response to Helicobacter induces gastric epithelial pathology will lay the foundation for further studies on the regulation of the inflammatory response and the design of immunotherapies for Helicobacter infection and associated digestive diseases.
描述(由申请人提供):细菌幽门螺杆菌是一种主要的病原体,除了感染世界一半以上的人群外,还与胃溃疡和十二指肠溃疡,与粘膜相关的淋巴瘤和腺癌有关。幽门螺杆菌感染导致嗜中性粒细胞,巨噬细胞,CD4+ T细胞和B细胞的早期胃浸润。这些胃浸润伴随着胃粘膜细胞的胃gamma,TNF-Alpha和IL-1的水平升高,胃壁细胞,酶促细胞和胃粘膜细胞的发育异常的损失。关于这种胃浸润诱导随后的胃上皮病理的机制知之甚少。一种小型动物模型的螺旋杆菌感染模型,H。felis小鼠模型,紧密地模仿了人类疾病,因为严重的胃萎缩和胃腺癌在感染后发展。该模型允许仔细分析对螺旋杆菌感染的自适应免疫反应。我们使用一种新型的疾病收养模型,我们表明是宿主CD4+ T细胞反应对于H. felis相关胃病理学的发展至关重要。这将我们的注意力转移到CD4+ T细胞的作用及其潜在效应器机制中,在与螺旋细菌相关的胃皮细胞破坏和病理学的发展中。该赠款的应用集中在胃中CD4+ T细胞的募集和激活导致二次非抗原特异性胃皮细胞改变的假设。上皮细胞增殖和分化的这些变化导致胃发育不良和癌症形成。为了阐明这种免疫/上皮细胞关系及其后遗症,我们建议:1)表征CD4+ T细胞的抗原识别要求,对于开发与螺旋细菌相关的胃病理至关重要; 2)确定分泌或细胞表面产物在与螺旋杆菌相关的胃上皮病理学产生中的作用。这些研究将利用体内疾病模型,以及一种新型的原发性胃皮细胞培养系统。对宿主对螺旋杆菌免疫反应诱导胃上皮病理的基本机制的理解将为进一步研究炎症反应的进一步研究以及针对螺旋杆菌感染和相关消化疾病的免疫疗法的设计。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robinna Gail Lorenz其他文献

Robinna Gail Lorenz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robinna Gail Lorenz', 18)}}的其他基金

Southeastern Medical Scientist Symposium
东南医学家研讨会
  • 批准号:
    9327579
  • 财政年份:
    2017
  • 资助金额:
    $ 27.55万
  • 项目类别:
Southeastern Medical Scientist Symposium
东南医学家研讨会
  • 批准号:
    8842667
  • 财政年份:
    2014
  • 资助金额:
    $ 27.55万
  • 项目类别:
Preparation for Graduate and Medical Education(PreGAME)Program
研究生和医学教育准备(PreGAME)计划
  • 批准号:
    9257456
  • 财政年份:
    2014
  • 资助金额:
    $ 27.55万
  • 项目类别:
Southeastern Medical Scientist Symposium
东南医学家研讨会
  • 批准号:
    8651000
  • 财政年份:
    2014
  • 资助金额:
    $ 27.55万
  • 项目类别:
Preparation for Graduate and Medical Education(PreGAME)Program
研究生和医学教育准备(PreGAME)计划
  • 批准号:
    8829327
  • 财政年份:
    2014
  • 资助金额:
    $ 27.55万
  • 项目类别:
Preparation for Graduate and Medical Education(PreGAME)Program
研究生和医学教育准备(PreGAME)计划
  • 批准号:
    8612197
  • 财政年份:
    2014
  • 资助金额:
    $ 27.55万
  • 项目类别:
EPITHELIAL AND INNATE SENSORS OF THE MICROBIOTA IN IBD
IBD 微生物群的上皮细胞和先天传感器
  • 批准号:
    7486782
  • 财政年份:
    2007
  • 资助金额:
    $ 27.55万
  • 项目类别:
EPITHELIAL AND INNATE SENSORS OF THE MICROBIOTA IN IBD
IBD 微生物群的上皮细胞和先天传感器
  • 批准号:
    6959577
  • 财政年份:
    2005
  • 资助金额:
    $ 27.55万
  • 项目类别:
T Cell Initiated Gastric Pathology
T 细胞引发的胃病理学
  • 批准号:
    6696919
  • 财政年份:
    2003
  • 资助金额:
    $ 27.55万
  • 项目类别:
T Cell Initiated Gastric Pathology
T 细胞引发的胃病理学
  • 批准号:
    6832252
  • 财政年份:
    2003
  • 资助金额:
    $ 27.55万
  • 项目类别:

相似国自然基金

靶向B细胞治疗系统性红斑狼疮的体内嵌合抗原受体T细胞(CAR-T)基因纳米递送体系的研究
  • 批准号:
    82302379
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
抗骨髓瘤的新型同种异体嵌合抗原受体T(CAR T)细胞疗法研发
  • 批准号:
    82270210
  • 批准年份:
    2022
  • 资助金额:
    68 万元
  • 项目类别:
    面上项目
靶向环瓜氨酸肽表位的嵌合抗原受体调节性T细胞免疫疗法(CCP-Car Treg)治疗类风湿关节炎的实验性研究
  • 批准号:
    82260327
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
基于细胞膜蛋白质组学的嵌合抗原受体T细胞治疗T-ALL的新策略及其机制研究
  • 批准号:
    82270236
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
探究影响靶向B7-H3的嵌合抗原受体T细胞治疗胶质母细胞瘤的相关机制
  • 批准号:
    82102898
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINS
基本标题:预防临床前药物开发计划:临床前疗效和中间终点 BIOMAKERSTASK 订单标题:再次疫苗
  • 批准号:
    10651935
  • 财政年份:
    2022
  • 资助金额:
    $ 27.55万
  • 项目类别:
Immune interactions with commensal microbes in early life
生命早期与共生微生物的免疫相互作用
  • 批准号:
    10567936
  • 财政年份:
    2022
  • 资助金额:
    $ 27.55万
  • 项目类别:
Defining receptor-ligand interactions in gastric epithelial immunosurveillance
定义胃上皮免疫监视中的受体-配体相互作用
  • 批准号:
    10652599
  • 财政年份:
    2022
  • 资助金额:
    $ 27.55万
  • 项目类别:
Defining receptor-ligand interactions in gastric epithelial immunosurveillance
定义胃上皮免疫监视中的受体-配体相互作用
  • 批准号:
    10517171
  • 财政年份:
    2022
  • 资助金额:
    $ 27.55万
  • 项目类别:
Determinants of induced Treg and inflammatory Th17 cell balance in response to potentially pathogenic microbiota
诱导 Treg 和炎症 Th17 细胞平衡响应潜在致病微生物群的决定因素
  • 批准号:
    10372223
  • 财政年份:
    2021
  • 资助金额:
    $ 27.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了